|
Mechanismβ-adrenoceptors antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1973 |
100 Clinical Results associated with Legacy Pharma LP
0 Patents (Medical) associated with Legacy Pharma LP
100 Deals associated with Legacy Pharma LP
100 Translational Medicine associated with Legacy Pharma LP